Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-10-20

Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients [Phase 1, Phase 2]

View source ↗

Summary

This document provides a clinical trial update on the use of Umbilical Cord Mesenchymal Stem Cells infused via the hepatic artery to treat liver cirrhosis. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery

Snippet

Sponsor: Qingdao University | Conditions: Liver Cirrhosis, Radiology | Phase 1, Phase 2 | Status: UNKNOWN